PMID- 24053213
OWN - NLM
STAT- MEDLINE
DCOM- 20140616
LR  - 20211021
IS  - 1464-410X (Electronic)
IS  - 1464-4096 (Print)
IS  - 1464-4096 (Linking)
VI  - 113
IP  - 5b
DP  - 2014 May
TI  - A national survey of radiation oncologists and urologists on recommendations of 
      prostate-specific antigen screening for prostate cancer.
PG  - E106-11
LID - 10.1111/bju.12422 [doi]
AB  - OBJECTIVE: To assess recommendations for prostate-specific antigen (PSA) 
      screening in a national survey of radiation oncologists and urologists following 
      the recent USA Preventive Services Task Force (USPSTF) grade D recommendation. 
      METHODS: A random sample of 1366 radiation oncologists and urologists were 
      identified from the American Medical Association Physician Masterfile. From 
      November 2011 to April 2012, a mail survey was sent to query PSA screening 
      recommendations for men at average risk of prostate cancer for the following age 
      groups: 40-49, 50-59, 60-69, 70-74, 75-79 and >/=80 years. Multivariable logistic 
      regression was used to test for differences in PSA-based screening 
      recommendations by physician characteristics. RESULTS: Response rates were 
      similar at 52% for radiation oncologists and urologists (P = 0.92). Overall, 
      51.5% of respondents recommended PSA-based screening for men aged 40-49 years, 
      while nearly all endorsed it for those aged 50-74 years (96.1% for 50-59, 97.3% 
      for 60-69, and 87.7% for 70-74 years). However, screening recommendations 
      decreased to 43.9% and 12.8% for men aged 75-79 and >/=80 years, respectively. On 
      multivariable analysis, urologists were more likely to recommend screening for 
      men aged 40-49 (odds ratio [OR] 3.09; P < 0.001) and 50-59 years (OR 3.81; P = 
      0.01), but less likely for men aged 75-79 (OR 0.66; P = 0.01) and >/=80 years (OR 
      0.45; P = 0.002) compared with radiation oncologists. CONCLUSION: While radiation 
      oncologists and urologists recommended PSA screening for men aged 50-69 years, 
      there was less agreement about screening for younger (40-49 years old) and older 
      (>/=70 years) men at average risk for prostate cancer.
CI  - (c) 2013 The Authors. BJU International (c) 2013 BJU International.
FAU - Kim, Simon P
AU  - Kim SP
AD  - Yale University School of Medicine, Department of Urology, New Haven, CT, USA; 
      Yale University, Cancer Outcomes, Public Policy, and Effectiveness Research 
      Center (COPPER), New Haven, CT, USA.
FAU - Karnes, R Jeffrey
AU  - Karnes RJ
FAU - Nguyen, Paul L
AU  - Nguyen PL
FAU - Ziegenfuss, Jeanette Y
AU  - Ziegenfuss JY
FAU - Thompson, R Houston
AU  - Thompson RH
FAU - Han, Leona C
AU  - Han LC
FAU - Shah, Nilay D
AU  - Shah ND
FAU - Smaldone, Marc C
AU  - Smaldone MC
FAU - Gross, Cary P
AU  - Gross CP
FAU - Frank, Igor
AU  - Frank I
FAU - Weight, Christopher J
AU  - Weight CJ
FAU - Beebe, Timothy J
AU  - Beebe TJ
FAU - Tilburt, Jon C
AU  - Tilburt JC
LA  - eng
GR  - UL1 TR000135/TR/NCATS NIH HHS/United States
PT  - Journal Article
DEP - 20140117
PL  - England
TA  - BJU Int
JT  - BJU international
JID - 100886721
RN  - EC 3.4.21.77 (Prostate-Specific Antigen)
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - Early Detection of Cancer/*standards
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Practice Guidelines as Topic
MH  - *Practice Patterns, Physicians'
MH  - Prostate-Specific Antigen/*blood
MH  - Prostatic Neoplasms/blood/*diagnosis
MH  - *Radiation Oncology
MH  - Surveys and Questionnaires
MH  - United States
MH  - *Urology
PMC - PMC4353641
MID - NIHMS517244
OTO - NOTNLM
OT  - outcomes
OT  - prostate cancer
OT  - prostate-specific antigen
OT  - screening
OT  - survey
COIS- Conflicts of Interest: All other authors have no conflicts of interest to 
      declare.
EDAT- 2013/09/24 06:00
MHDA- 2014/06/17 06:00
PMCR- 2015/05/01
CRDT- 2013/09/24 06:00
PHST- 2013/09/24 06:00 [entrez]
PHST- 2013/09/24 06:00 [pubmed]
PHST- 2014/06/17 06:00 [medline]
PHST- 2015/05/01 00:00 [pmc-release]
AID - 10.1111/bju.12422 [doi]
PST - ppublish
SO  - BJU Int. 2014 May;113(5b):E106-11. doi: 10.1111/bju.12422. Epub 2014 Jan 17.